Patient intervention against tachyarrhythmia treatment

By communicating with the IMD via an external device, patients or their caregivers can adjust the ICD's treatment plan, resolving the issue of unnecessary electric shocks from the ICD and improving treatment accuracy and patient comfort.

CN118946384APending Publication Date: 2024-11-12MEDTRONIC INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380030485.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-03-31
Filing Date
2023-03-30
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

Existing implantable cardioverter defibrillators (ICDs) may deliver unnecessary shocks when they detect tachyarrhythmias, causing emotional distress to patients, and existing systems struggle to effectively utilize patient involvement to adjust treatment plans.

Method used

Communicating with an implantable medical device (IMD) via an external device allows patients or their caregivers to input adjustments to treatment plans, including delaying or replacing treatments, and reducing unnecessary electric shocks.

Benefits of technology

By involving patients in adjusting treatment plans, unnecessary electric shocks are reduced, and the precision of treatment and patient comfort are improved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118946384A_ABST
    Figure CN118946384A_ABST
Patent Text Reader

Abstract

A medical system includes an implantable medical device (IMD) configured to detect an arrhythmia of a patient; and an external device comprising processing circuitry and configured to receive, from the IMD, an indication that the IMD has detected the arrhythmia of the patient; generating an output indicating that the IMD has detected the arrhythmia; receiving an input from a user; and in response to the input from the user, sending a command to the IMD to cause the IMD to modify a treatment plan determined by the IMD.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application claims the benefit of U.S. Provisional Patent Application No. 63 / 362,300, filed on March 31, 2022, the entire contents of which are incorporated herein by reference. Technical Field

[0002] The present disclosure relates generally to medical devices, and more particularly to techniques and devices for delivering anti-tachyarrhythmia therapy to a patient. Background Art

[0003] Malignant tachyarrhythmias (e.g., ventricular fibrillation) are uncoordinated contractions of the heart muscle of the heart's ventricles and are the most common arrhythmias in cardiac arrest patients. If such arrhythmias persist for more than a few seconds, cardiogenic shock and cessation of effective blood circulation may result. As a result, sudden cardiac death (SCD) may occur within minutes.

[0004] In patients at high risk for ventricular fibrillation, the use of implantable medical devices (IMDs), such as implantable cardioverter-defibrillators (ICDs), has been shown to be beneficial in preventing SCD. An ICD is a battery-powered shock device that may include an electrical shell electrode (sometimes referred to as a can electrode) that is typically coupled to one or more leads having one or more additional electrodes. The lead electrodes may be placed inside or outside the heart, such as under the skin or under the sternum. If an arrhythmia is sensed, the ICD may deliver an anti-tachyarrhythmia shock (e.g., cardioversion or defibrillation shock) to shock the heart and restore the normal rhythm of the heart. Some ICDs have been configured to attempt to terminate a detected tachyarrhythmia by delivering anti-tachycardia pacing (ATP) before delivering the shock. In addition, the ICD has been configured to deliver a relatively high magnitude post-shock pacing after successfully terminating a tachyarrhythmia with a shock in order to support the heart in recovering from the shock. Some ICDs also deliver bradycardia pacing, cardiac resynchronization therapy (CRT), or other forms of pacing. Summary of the invention

[0005] According to one example, a method includes: receiving at an external device an indication from an implantable medical device (IMD) implanted in a patient that the IMD has detected an arrhythmia in the patient; generating, by the external device, an output indicating that the IMD has detected the arrhythmia; receiving at the external device an input from a user of the external device; and in response to the input from the user, sending a command from the external device to the IMD to cause the IMD to modify a treatment plan determined by the IMD.

[0006] According to another example, a device includes: a memory; and a processing circuit coupled to the memory and configured to: receive an indication from an implantable medical device (IMD) implanted in a patient that the IMD has detected an arrhythmia in the patient; generate an output indicating that the IMD has detected the arrhythmia; receive input from a user of the external device at an external device; and in response to the input from the user, send a command to the IMD to cause the IMD to modify a treatment plan determined by the IMD.

[0007] According to another example, a system includes: an implantable medical device (IMD) configured to detect a cardiac arrhythmia in a patient; and an external device including a processing circuit and configured to: receive an indication from the IMD that the IMD has detected the arrhythmia in the patient; generate an output indicating that the IMD has detected the arrhythmia; receive input from a user; and in response to the input from the user, send a command to the IMD to cause the IMD to modify a treatment plan determined by the IMD.

[0008] The present disclosure is intended to provide an overview of the subject matter described in the present disclosure. It is not intended to provide an exclusive or exhaustive explanation of the devices and methods described in detail in the following figures and descriptions. Further details of one or more examples are set forth in the following figures and descriptions. BRIEF DESCRIPTION OF THE DRAWINGS

[0009] Figure 1 is a block diagram illustrating an exemplary system for predicting and treating cardiac arrhythmias in accordance with the techniques of this disclosure.

[0010] Figure 2 is a front view of a patient with an extracardiovascular ICD system implanted within the thorax.

[0011] Figure 3 is an example Figure 1 Block diagram of an exemplary configuration of an implantable medical device (IMD).

[0012] Figure 4A is an example Figure 1 A functional block diagram of an exemplary configuration of an external device.

[0013] Figure 4B and Figure 4C Shows Figure 4A Examples of external devices in .

[0014] Figure 5 A flow chart of a process that may be performed by an IMD and an external computing device is shown.

[0015] Figure 6A flow chart illustrating a process that may be performed by an IMD without an external computing device.

[0016] Figure 7 Shows that Figure 6 An exemplary device for use in combination with the technology.

[0017] Like reference numerals refer to like elements throughout the drawings and the specification. DETAILED DESCRIPTION

[0018] A large portion of the tachyarrhythmias treated are due to supraatrial tachycardia, sinus tachycardia, or oversensing, and the use of an extravascular implantable cardioverter-defibrillator (EV-ICD) may increase the incidence of tachyarrhythmias. Although other arrhythmias are dangerous and may develop into VT and VF, it is possible that other interventions (such as anti-rapid pacing) or patient interventions (such as cessation of activity or mindfulness exercises) may also effectively terminate the arrhythmia or murmur. An implantable cardioverter-defibrillator (ICD) can treat tachyarrhythmias using high-voltage defibrillation therapy, which may be referred to as electric shock in this article. However, not all detected tachyarrhythmias necessarily require electric shocks, and inappropriate electric shocks can cause great emotional damage to ICD patients.

[0019] Avoidance of certain activities has been noted in some ICD patients as a mechanism for preventing or stopping tachyarrhythmias. The systems and techniques described in the present disclosure include involving patients in triage and treatment plans when tachyarrhythmias are occurring. Including patients in treatment plans can reduce the number of inappropriate shocks and provide meaningful data to improve algorithms for determining when to deliver shocks.

[0020] An exemplary system of the present disclosure includes an implantable medical device (IMD), such as an ICD; and an external device that communicates with the IMD. The external device may be any of a smart phone, a tablet computer, a smart watch, a patient controller, or any other such device capable of communicating with the IMD. According to one example of the technology described herein, the IMD may detect a patient's arrhythmia and transmit an indication to the external device that the IMD has detected the patient's arrhythmia. In some examples, the IMD establishes a secure telemetry session with the external device after detecting an arrhythmia attack to facilitate the transmission of data / commands. In response to receiving an indication from the IMD, the external device then generates an output indicating that the IMD has detected an arrhythmia. The output may be, for example, any of an audio signal, a visual signal, or a tactile signal for alerting a user of the external device that the IMD has detected an arrhythmia.

[0021] The external device may then solicit input from the user regarding a treatment plan for the arrhythmia. For example, the user may be able to indicate that the patient is ready to receive an electric shock or that the patient wishes to delay treatment and wait to see if the arrhythmia will disappear without treatment. In some examples, the patient may select an alternative treatment, such as a lower voltage electric shock or pacing therapy. In response to input from the user, the external device sends a command to the IMD to cause the IMD to modify the treatment plan predetermined by the IMD. Modifications to the treatment plan may include, for example, delaying the delivery of an electric shock to the patient, speeding up the delivery of an electric shock to the patient, or delivering an alternative treatment. Modifications to the treatment plan may include modifying the treatment plan for the current arrhythmia or modifying either or both of the treatment plan for future arrhythmias of the same or similar type. In some implementations, the external device may additionally recommend actions to the patient, such as stopping activity or breathing exercises, to reduce the likelihood of needing an electric shock.

[0022] In an exemplary implementation, the IMD may set an initial treatment plan in response to detecting an arrhythmia, and then modify the initial treatment plan based on input received from a user via an external device. For example, in response to detecting an arrhythmia, the IMD may start an initial counter to set the time to deliver a shock to the patient. The initial counter may be, for example, 30 seconds or any other predetermined amount of time. In response to receiving an input from a user via an external device indicating that the patient is ready to receive a shock, the IMD may deliver the shock before 30 seconds. In response to receiving an input from a user via an external device indicating that the patient wants to wait to see if the arrhythmia will disappear without a shock, the IMD may extend the counter to 90 seconds (or any other duration) and deliver a shock after 90 seconds, or if the arrhythmia disappears within 90 seconds, no shock is delivered. In a scenario where the IMD cannot establish a connection with an external device or does not receive user input, the IMD may deliver a shock after the original counter reaches 30 seconds.

[0023] Although it is expected that in many use cases, the user of the external device will be the same person as the patient using the IMD, it is not necessarily required that the user be the same person as the patient. For example, the user may be a caregiver or family member of the patient.

[0024] Figure 1 is a block diagram illustrating an exemplary system for predicting and treating cardiac arrhythmias according to the techniques of the present disclosure. System 2 includes a medical device. An example of such a medical device is Figure 1 The IMD 10 depicted in FIG. Figure 1As illustrated in the exemplary system 10 in FIG. 1 , in some examples, IMD 10 can be, for example, an implantable cardiac pacemaker, an implantable cardioverter / defibrillator (ICD), or a pacemaker / cardioverter / defibrillator. IMD 10 is connected to leads 18, 20, and 22 and is communicatively coupled to an external device 12, which in turn is communicatively coupled to a computing device 24 on a communications network 25.

[0025] IMD 10 senses electrical signals, such as an electrocardiogram (EGM), accompanying depolarization and repolarization of heart 6 via one or more leads 18, 20, and 22 or electrodes on the housing of IMD 10. IMD 10 may also deliver therapy to heart 6 in the form of electrical signals via electrodes located on one or more leads 18, 20, and 22 or the housing of IMD 10. The therapy may be a pacing pulse, a cardioversion pulse, and / or a defibrillation pulse. IMD 10 may monitor the EGM signals collected by the electrodes on leads 18, 20, or 22, and based on the EGM signals, diagnose and treat a heart attack.

[0026] Leads 18, 20, 22 extend into the heart 6 of the patient 4 to sense the electrical activity of the heart 6 and / or deliver electrical stimulation to the heart 6. Figure 1 In the example shown, right ventricular (RV) lead 18 extends through one or more veins (not shown), the superior vena cava (not shown), and the right atrium 26, and into the right ventricle 28. Left ventricular (LV) lead 20 extends through one or more veins, the vena cava, the right atrium 26, and into the coronary sinus 30 to a region adjacent to the free wall of the left ventricle 32 of the heart 6. Right atrial (RA) lead 22 extends through one or more veins and the vena cava, and into the right atrium 26 of the heart 12. The techniques of the present disclosure may also be implemented by other types of ICDs, such as leadless ICDs that do not use transvenous leads.

[0027] IMD 10 includes a plurality of electrodes ( Figure 1 1 and 2 (not shown), and is configured to sense cardiac EGM via a plurality of electrodes. Some or all of these electrodes may be located, for example, on leads 18, 20, and 22. IMD 10 may also include additional sensors, such as optical sensors and impedance sensors. IMD 10 may be configured to detect arrhythmias in patient 4. In this case, in addition to detecting active arrhythmias, detecting arrhythmias may also include detecting an arrhythmia about to occur or determining that patient 4 is at an increased risk of having an arrhythmia.

[0028] External device 12 is a computing device configured for wireless communication with IMD 10. External device 12 may be configured to communicate with computing system 24 via network 25. In some examples, external device 12 may provide a user interface and allow a user to interact with IMD 10. Computing system 24 may include a computing device configured to allow a user to interact with IMD 10 or data collected from the IMD via network 25.

[0029] External device 12 may be used to retrieve data from IMD 10 and may send the data to computing system 24 via network 25. The retrieved data may include values ​​of physiological parameters measured by IMD 10, indications of the onset of an arrhythmia or other disease detected by IMD 10, episode data collected for the episode, and other physiological signals recorded by IMD 10. The episode data may include an EGM segment recorded by IMD 10, e.g., because IMD 10 determined that the onset of an arrhythmia or another disease occurred during the segment, or in response to a request to record a segment from patient 4 or another user.

[0030] In some examples, computing system 24 includes one or more handheld computing devices, computer workstations, servers, or other networked computing devices. In some examples, computing system 24 may include one or more devices that include processing circuitry and storage devices. Computing system 24 and network 25 may be provided in whole or in part by Medtronic Carelink. TM Network or other patient monitoring system implementation.

[0031] The network 25 may include one or more computing devices (not shown), such as one or more non-edge switches, routers, hubs, gateways, security devices (such as firewalls), intrusion detection and / or intrusion prevention devices, servers, computer terminals, laptops, printers, databases, wireless mobile devices (such as cellular phones or personal digital assistants), wireless access points, bridges, cable modems, application accelerators, or other network devices. The network 25 may include one or more networks managed by a service provider, and thus may form part of a large-scale public network infrastructure (e.g., the Internet). The network 25 may provide access to the Internet to computing devices (such as computing system 24 and IMD 10), and may provide a communication framework that allows computing devices to communicate with each other. In some examples, the network 25 may be a dedicated network that provides a communication framework that allows the computing system 24, IMD 10, and / or external device 12 to communicate with each other but separates one or more of the computing system 24, IMD 10, or external device 12 from devices outside the network 25 for security purposes. In some examples, communications between computing system 24, IMD 10, and external device 12 are encrypted.

[0032] As discussed in more detail below, the IMD 10 may be configured to detect arrhythmias and, in response to detecting an arrhythmia, set an initial treatment plan for the patient 4. The initial treatment plan may be, for example, that the IMD will wait 45 seconds to see if the arrhythmia will disappear, and if the arrhythmia does not disappear, a high voltage shock is delivered to the patient 4. The IMD 10 may also attempt to establish a communication session with the external device 12 after the detection interval ends or during the detection interval, and if the communication session can be established, an indication that the IMD 10 has detected an arrhythmia of the patient 4 is sent to the external device 12. In some examples, the communication session is a secure telemetry session. The external device 12 may be configured to receive an indication that the IMD 10 has detected an arrhythmia of the patient 4 from the IMD 10, for example via wireless communication, and generate an output in response. The output may, for example, solicit one or more inputs from the patient 4 or from another user of the external device 12. Based on the input received from the patient 4, the external device 12 may send a command to the IMD 10 to cause the IMD 10 to modify the initial treatment plan.

[0033] An example of the one or more inputs that the external device 12 may solicit from the patient 4 includes allowing the user to choose between a first option of waiting to see if the arrhythmia will disappear without treatment or a second option of delivering treatment immediately. In some examples, the external device 12 may also present the patient 4 with the option of receiving an alternative (usually milder) treatment. In response to the patient 4 selecting the first option, the external device 12 may send a command to the IMD 10 to increase the amount of time that the IMD 10 will wait before delivering a shock to the patient 4. In response to the patient 4 selecting the first option, the computing system 10 may additionally output a recommended action to the patient 4, such as stopping any high-intensity activity, sitting down, or breathing rhythmically. In response to the patient 4 selecting the second option, the external device 12 may send a command to the IMD 10 to increase the amount of time that the IMD 10 will wait before delivering a shock to the patient 4 (e.g., increasing the time from 30 seconds to 90 seconds or other predetermined amount of time). In response to patient 4 selecting the third option, external device 12 may send a command to IMD 10 to cause IMD 10 to deliver the alternative therapy. In response to external device 12 not receiving any input from patient 4, external device 12 may cause IMD 10 to deliver the initial therapy plan.

[0034] In an exemplary implementation, the external device 12 may be configured to present some or all of the above options in response to the IMD 10 detecting an arrhythmia. In some implementations, the external device 12 may first solicit patient status input from the patient 4 to allow the patient 4 to enter information about its current state. Based on these patient status inputs, the external device 12 may present the option of postponing shock or accepting alternative treatment to the patient 4 only when it is deemed appropriate based on the patient's status. In some implementations, the external device 12 may solicit status input from the patient 4 after the patient 4 selects the first option of postponing treatment or the third option of accepting alternative treatment, and then based on the status input, determine the appropriate amount of time to delay treatment or the appropriate alternative treatment based on determining how serious the threat caused by the arrhythmia is. In some other implementations, the patient 4 may not make a clear choice of postponing treatment or accepting alternative treatment, but the external device 12 may make this determination based on the status input.

[0035] In some examples, the options presented to patient 4 by external device 12 may depend on the severity of the arrhythmia detected by IMD 10. For example, external device 12 may not present the option to defer treatment or the option to receive an alternative treatment if the arrhythmia is deemed to be of imminent danger to patient 4, or may not present the option to receive an alternative treatment if the arrhythmia is determined to be of a type that will likely not respond to an alternative treatment.

[0036] Examples of one or more status inputs that external device 12 may solicit from patient 4 include information such as an indication of how active patient 4 has been recently. For example, patient 4 may provide an input of 1 to 5, 1 to 10, or a selection of options such as low, normal, or high to indicate a recent activity level. Another example of status input that external device 12 may solicit from patient 4 includes an indication of whether patient 4 has missed a dose of any medication that patient 4 takes regularly. For example, during the setup phase, patient 4 may store a list of one or more medications that patient 4 habitually takes or the types or uses of medications that patient 4 habitually takes. Then, in response to IMD 10 detecting an arrhythmia, external device 12 may ask patient 4 to confirm that he or she has not missed any doses of these medications. Another example of status input that external device 12 may solicit from patient 4 includes information about whether patient 4 has recently taken medication or consumed alcohol.

[0037] In one specific example, in response to IMD 10 detecting an arrhythmia in patient 4, external device 12 may solicit from patient 4 an indication of how active patient 4 is. Since it is expected that high levels of activity naturally result in a significant increase in patient 4's heart rate and increase the likelihood of IMD 10 detecting a false positive, external device 12 may defer treatment without any other input from patient 4 as long as patient 4's heart rhythm appears to be improving or not getting worse. However, if patient 4's heart rhythm does not improve within a certain amount of time, external device 12 may present to patient 4 the option of immediately receiving a high voltage shock, receiving an alternative treatment, or continuing to defer treatment. If, after a certain number of deferrals, patient 4's heart rhythm still has not improved sufficiently, external device 12 may stop offering patient 4 the option of deferring and alert patient 4 that they need to prepare to receive a shock.

[0038] In another example, in response to IMD 10 detecting an arrhythmia in patient 4, external device 12 may solicit from patient 4 an indication of how active patient 4 is (e.g., prompting confirmation of whether patient 4 is exercising and / or at what intensity), and patient 4 may indicate that they are moderately active. In the absence of significant activity, patient 4 will generally be less likely to have an increased heart rate, and IMD 10 may be less likely to detect a false positive. Thus, external device 12 may be configured to not present to patient 4 an option to defer treatment or to reduce the amount of time or number of times patient 4 may defer compared to when patient 4 indicates high activity.

[0039] In another example, in response to IMD 10 detecting an arrhythmia of patient 4, external device 12 may request from patient 4 an indication of whether patient 4 has missed a dose of a cardiac rhythm medication. Since patient 4 taking a cardiac rhythm medication may increase the likelihood that a detected arrhythmia is a false positive or that the arrhythmia will disappear without treatment, external device 12 may present to patient 4 an option to postpone treatment for a certain amount of time. However, if patient 4 indicates that they have missed a dose of their cardiac rhythm medication, external device 12 may not present to patient 4 an option to postpone treatment for a certain amount of time, but instead provide patient 4 with a notification to prepare for a shock. In other examples, if patient 4 indicates that they have missed a dose of their cardiac rhythm medication, external device 12 may still present to patient 4 an option to postpone treatment, but only for a smaller amount of time if patient 4 has taken their medication. In some examples, if patient 4 indicates that they have missed a dose of their medication, the number of times that patient 4 is allowed to postpone treatment may be lower than if they have not missed a dose.

[0040] In another example, in response to IMD 10 detecting an arrhythmia in patient 4, external device 12 may solicit from patient 4 an indication of whether patient 4 has recently taken medication, consumed drugs, or consumed alcohol. If patient 4 confirms that they have taken medication, consumed drugs, or consumed alcohol, the external device may solicit additional input regarding the amount and type of drugs or alcohol. Because certain drugs, medications, or combinations may significantly increase the likelihood of life-threatening arrhythmias, if patient 4 indicates that they have recently taken medications such as stimulants, external device 12 does not present to patient 4 the option of deferring treatment or receiving an alternative treatment, but may notify patient 4 that they need to prepare to receive a shock.

[0041] The various status inputs described above may be used in any combination or permutation to determine the various options presented to patient 4 by external device 12. For example, if patient 4 indicates that they have not missed any medications, are moderately active, and have not taken any medications, drugs, or consumed alcohol, external device 12 may allow patient 4 to defer therapy an unlimited number of times as long as the severity of the detected arrhythmia has not worsened, and may present the option of trying an alternative therapy to patient 4. However, if patient 4 indicates that they have missed medications or have already taken medications, external device 12 may not present the option of an alternative therapy to patient 4 and may only allow patient 4 to defer therapy a limited number of times before delivering a shock.

[0042] In another example, when an arrhythmia is detected in patient 4, external device 12 may present patient 4 with an option to postpone a shock based on a detected activity level of patient 4. The activity level may be detected, for example, by an accelerometer in IMD 10 or in another medical device (such as another implanted medical device, a wearable device, external device 12, another user device, or other such device). In response to detecting an arrhythmia in patient 4 and detecting the presence of activity, external device 12 may additionally present patient 4 with a notification to reduce or cease activity.

[0043] In another example, when an arrhythmia is detected in patient 4, external device 12 may present patient 4 with an option to postpone a shock based on the detected respiration level of patient 4. The respiration level may be detected, for example, by a sensor in IMD 10 or in another medical device, such as another implanted medical device or a wearable device. In response to detecting an arrhythmia in patient 4 and detecting the presence of a high respiration level, external device 12 may additionally present patient 4 with a notification to engage in breathing exercises or otherwise reduce the patient's respiration level.

[0044] In some examples, external device 12 may output a timer to patient 4 showing the amount of time that patient 4 has to choose between the various options presented. If patient 4 does not select an option within the specified time, the computing system may not transmit any command to IMD 10 so that IMD 10 continues to follow the initial treatment plan, or external device 12 may transmit a message to IMD 10 indicating that patient 4 has not yet responded. If patient 4 chooses to postpone treatment, the timer may be updated to reflect the increased amount of time brought about by the postponement. External device 12 may be configured to allow patient 4 to postpone treatment multiple times, but after a certain number of postponements or in response to determining that the arrhythmia has not stopped, external device 12 may stop providing patient 4 with the option of postponing treatment at a certain point in time (e.g., after a predetermined amount of time or a predetermined number of postponements).

[0045] The external device 12 may be configured to store the selections made by the user and associate these selections with the results for the patient 4. For example, the external device 12 may store an indication of whether the arrhythmia will disappear without any treatment, whether it will disappear with alternative treatment, or whether a high voltage shock is required. The external device 12 may then customize the options presented based on these results. For example, if for certain types of arrhythmias, alternative treatments are proven to be unsuccessful in making the arrhythmia disappear, the external device 12 may stop presenting alternative treatments as an option to the patient 12. For another example, based on the stored results, the external device 12 may determine that for the patient 4, high activity typically corresponds to false positives or heart rates that disappear without intervention, while arrhythmias detected at moderate activity levels often do not disappear without treatment. The external device 12 may then customize the options presented to the user accordingly.

[0046] With respect to customizing options based on the results, such functionality may be implemented by the computing system 24 rather than the external device 12, or by the computing system in conjunction with the external device. In addition, the computing system 24 may store such information for a large number of patients, and this data may be used to update determinations made by the external device 12. In some cases, the external device 12 may be configured to query the computing system 24 in real time (e.g., when an arrhythmia occurs), and the computing system 24 may provide recommended options to the external device 12 for presentation to the user. The computing system 24 may determine the recommended options based on the determined arrhythmia type and information about the status of the patient 4 provided by the user of the external device 12. The external device 12 may also be configured to notify the computing system 24 of the number of times that the patient 4 has postponed treatment, so that the clinician can determine whether the parameters of the ICD 10 need to be modified or whether the treatment plan of the patient 4 needs to be modified in other ways.

[0047] Figure 2is a front view of a patient 4 implanted with an extracardiovascular ICD system 3 implanted in the thorax. The ICD system 3 includes an ICD 9 connected to an implantable medical lead 34. The ICD 9 can interact with an external device 12 in the same manner as the ICD 10 described above. That is, the ICD 9 can be configured to detect an arrhythmia and set an initial treatment plan for the patient 4 in response to detecting the arrhythmia. The initial treatment plan can be, for example, that the ICD 9 will wait 45 seconds to see if the arrhythmia will disappear, and if the arrhythmia does not disappear, a high voltage shock is delivered to the patient 4. The ICD 9 can also attempt to establish a communication session with the external device 12, and if the communication session can be established, an indication that the ICD 9 has detected an arrhythmia in the patient 4 is sent to the external device 12. In some examples, the communication session is a secure telemetry session. The external device 12 can be configured to receive an indication that the ICD 9 has detected an arrhythmia in the patient 4 from the ICD 9, for example via wireless communication, and generate an output in response. The output may, for example, solicit one or more inputs from patient 4 or from another user of external device 12. Based on the inputs received from patient 4, external device 12 may send commands to ICD 9 to cause ICD 9 to modify the initial treatment plan.

[0048] ICD 9 may include an outer shell that forms an airtight seal that protects the components of ICD 9. The outer shell of ICD 9 may be formed of a conductive material such as titanium or a titanium alloy, which may be used as an outer shell electrode (sometimes referred to as a can electrode). In some embodiments, ICD 9 may be formed to have or may include multiple electrodes on the outer shell. ICD 9 may also include a connector assembly (also referred to as a connector block or plug) that includes electrical feedthroughs through which electrical connections are made between conductors of leads 34 and electronic components included in the outer shell of ICD 9. As will be described in further detail herein, the outer shell may house one or more processors, memories, transmitters, receivers, sensors, sensing circuits, treatment circuits, power supplies, and other suitable components. The outer shell is configured to be implanted in a patient (such as patient 4).

[0049] ICD 9 is implanted outside the left thorax of patient 4, for example, under the skin and outside the thorax (subcutaneous or submuscular). In some cases, ICD 9 may be implanted between the left posterior axillary line and the left anterior axillary line of the patient. However, as described later, ICD 9 may be implanted in other extrathoracic locations of the patient.

[0050] Lead 34 may include an elongated lead body 13 having a distal portion 15 sized to be implanted in an extracardiac location proximal to the heart, such as within the thorax. For example, lead 34 may extend from ICD 9 toward the center of patient 4's torso (e.g., toward patient 4's xiphoid process) beneath the skin and outside the thorax (e.g., subcutaneously or submuscularly). At a location proximal to the xiphoid process, lead body 13 may be bent or otherwise rotated upward and extended. The bend may be preformed and / or lead body 13 may be flexible to facilitate the bend. Figure 2 In the illustrated example, the lead body 13 extends upward within the thorax below the sternum in a direction substantially parallel to the sternum.

[0051] Lead body 13 may extend upwardly outside the thorax (rather than inside the thorax), such as subcutaneously or submuscularly above the thorax / sternum. Lead 34 may be implanted at other locations, such as above the sternum, offset to the right of the sternum, angled laterally from the proximal or distal end of the sternum, etc. In some examples, lead 34 may be implanted in an extracardiac vessel within the thorax, such as the ITV, intercostal veins, superior epigastric veins or the azygos, hemiazygos, and accessory hemiazygos veins. In some examples, the orientation of distal portion 15 of lead 34 may be different from that of the distal portion 15 of lead 34. Figure 2 , such as orthogonal to or otherwise transverse to the sternum 38 and / or below the heart 6. In such examples, the distal portion 15 of the lead 34 may be located at least partially within the anterior mediastinum of the patient 4. In some examples, the distal portion 15 of the lead 34 may be placed between the heart and the lungs and within the pleural cavity.

[0052] The lead body 13 may include a proximal end 15 and a distal portion 15, which includes an electrode configured to deliver electrical energy to the heart or sense electrical signals of the heart. The distal portion 15 can be anchored to a desired location in the patient's body, such as under the sternum or subcutaneously, by, for example, suturing the distal portion 15 to the patient's muscle tissue, tissue or bone at the xiphoid process entry site. In some examples, the distal portion 15 can be anchored to the patient or by using rigid tines, prongs, barbs, clips, screws and / or other protruding elements or flanges, discs, compliant tines, flaps, porous structures such as mesh elements, and metal or non-metal stents that promote tissue growth for engagement, bioadhesive surfaces and / or any other non-piercing elements.

[0053] The lead body 13 may define a substantially linear portion 36 when it bends or curves near the xiphoid process 23 and extends upward. Figure 2As shown, at least a portion of the distal portion 15 can define a wavy configuration distal to the substantially linear portion 36. In particular, the distal portion 15 can define a wavy pattern, such as a sawtooth, zigzag, sinusoidal, serpentine, or other pattern, as it extends toward the distal end of the lead 34. In other configurations, the lead body 13 can have no substantially linear portion 36 as it extends upward, but can begin the wavy configuration immediately after the bend.

[0054] The distal portion 15 includes one or more defibrillation electrodes configured to deliver an anti-tachyarrhythmia, such as cardioversion / defibrillation, electric shock to the heart 6 of the patient 4. In some examples, the distal portion 15 includes a plurality of defibrillation electrodes spaced a certain distance from each other along the length of the distal portion 15. Figure 2 In the illustrated example, the distal portion 15 includes two defibrillation electrodes 42a and 42b (collectively referred to as “defibrillation electrodes 42 ”).

[0055] The defibrillation electrodes 42 may be disposed around or within the lead body 13 of the distal portion 15, or alternatively, may be embedded within the wall of the lead body 13. In one configuration, the defibrillation electrodes 42 may be coil electrodes formed of a conductor. The conductor may be formed of one or more conductive polymers, ceramics, metal-polymer composites, semiconductors, metals, or metal alloys, including but not limited to one of platinum, tantalum, titanium, niobium, zirconium, ruthenium, indium, gold, palladium, iron, zinc, silver, nickel, aluminum, molybdenum, stainless steel, MP35N, carbon, copper, polyaniline, polypyrrole, and other polymer combinations. In another configuration, each of the defibrillation electrodes 42 may be a flat ribbon electrode, a paddle electrode, a braided or woven electrode, a mesh electrode, a directional electrode, a patch electrode, or another type of electrode configured to deliver a cardioversion / defibrillation shock to the heart 6 of the patient 4.

[0056] The defibrillation electrodes 42 may be electrically connected to one or more conductors that may be disposed in a body wall of the lead body 13 or in one or more insulating lumens (not shown) defined by the lead body 13. In an exemplary configuration, each of the defibrillation electrodes 42 is connected to a common conductor so that a voltage may be applied to all of the defibrillation electrodes 42 simultaneously to deliver an anti-tachyarrhythmia shock to the heart 6. In other configurations, the defibrillation electrodes 28 may be attached to separate conductors so that each defibrillation electrode 42 may have a voltage applied to it independently of the other defibrillation electrodes 42. In such a case, the ICD 9 or lead 34 may include one or more switches or other mechanisms to electrically connect the defibrillation electrodes together to serve as common polarity electrodes so that, in addition to being able to apply voltage independently, a voltage may be applied to all of the defibrillation electrodes 42 simultaneously.

[0057] The distal portion 15 may also include one or more pacing and / or sensing electrodes configured to deliver pacing pulses to the heart 6 and / or sense the electrical activity of the heart 6. Such electrodes may be referred to as pacing electrodes, sensing electrodes, or pacing / sensing electrodes. Figure 2 In the illustrated example, the distal portion 15 includes two pacing / sensing electrodes 44a and 44b (collectively referred to as “pacing / sensing electrodes 44 ”).

[0058] exist Figure 2 In some examples, the pace / sense electrode 44b is positioned between the defibrillation electrodes 42, e.g., within a gap between the defibrillation electrodes, and the pace / sense electrode 44a is positioned closer to the proximal defibrillation electrode 42a along the distal portion 15. In some examples, there may be more than one electrode 44 within a gap between the defibrillation electrodes 42. In some examples, the electrode 44 is additionally or alternatively located distally of the most distal defibrillation electrode 42b.

[0059] The electrodes 44 may be configured to deliver low voltage electrical pulses to the heart or may sense cardiac electrical activity, such as depolarization and repolarization of the heart. Therefore, the electrodes 44 may be referred to herein as pacing / sensing electrodes 44. In one configuration, the electrodes 44 are ring electrodes. However, in other configurations, the electrodes 44 may be any of a variety of different types of electrodes, including ring electrodes, short coil electrodes, paddle electrodes, hemispherical electrodes, or directional electrodes. Each of the electrodes 44 may be an electrode of the same or different type as another electrode in the electrodes 44. The electrodes 44 may be electrically isolated from the adjacent defibrillation electrodes 42 by including an electrically insulating layer of material between the electrodes 44 and the adjacent defibrillation electrodes 42. Each electrode 44 may have its own separate conductor so that a voltage may be applied to each electrode or sensed via each electrode independently of the other electrodes 44.

[0060] Electrode 42 is referred to as a defibrillation electrode, and electrode 44 is referred to as a pacing / sensing electrode, because they may have different physical structures, thereby achieving different functions. Defibrillation electrode 42 may be larger than pacing / sensing electrode 44, for example, having a larger surface area, and thus may be configured to deliver an anti-tachyarrhythmia shock having a relatively higher voltage than a pacing pulse. The relatively smaller size of pacing / sensing electrode 44 may provide advantages over defibrillation electrodes for delivering pacing pulses and sensing intrinsic cardiac activity, for example, a lower pacing capture threshold and / or better sensing signal quality. However, defibrillation electrode 42, such as in combination with pacing / sensing electrode 44, may be used to deliver pacing pulses and / or sense electrical activity of the heart.

[0061] In some examples, when the distal portion 15 is implanted outside a cardiovascular device, the pacing / sensing electrodes 44 and the defibrillation electrodes 42 may be disposed in a common plane. In other configurations, the wavy configuration may not be substantially disposed in a common plane. For example, the distal portion 15 may define a concavity or curvature.

[0062] The proximal end 14 of the lead body 13 may include one or more connectors 40 to electrically couple the lead 34 to the ICD 9. The ICD 9 may also include a connector assembly including electrical feedthroughs through which electrical connections are made between the one or more connectors 40 of the lead 34 and the electronic components included in the housing. The housing of the ICD 9 may house one or more processors, memories, transmitters, receivers, sensors, sensing circuits, treatment circuits, power sources (capacitors and batteries), and / or other components. The components of the ICD 9 may generate and deliver electrical therapy, such as anti-tachycardia pacing, cardioversion or defibrillation shocks, post-shock pacing, and / or bradycardia pacing.

[0063] The wavy configuration of distal portion 15 and the inclusion of electrodes 44 between defibrillation electrodes 42 can provide multiple therapy vectors for delivering electrical therapy to the heart. For example, at least a portion of defibrillation electrodes 42 and one of electrodes 44 can be disposed over the right ventricle or any chamber of the heart so that pacing pulses and anti-tachyarrhythmia shocks can be delivered to the heart. The housing of ICD 9 can be charged or used as a polarity different from the polarity of one or more defibrillation electrodes 42 and / or electrodes 44 so that electrical energy can be delivered to the heart between the housing and defibrillation electrodes 42 and / or electrodes 44.

[0064] When voltage is applied to each defibrillation electrode 42, each defibrillation electrode may have the same polarity as each other defibrillation electrode 42 so that a defibrillation shock may be delivered together from all defibrillation shocks. In examples where the defibrillation electrodes 42 are electrically connected to a common conductor within the lead body 13, this is the only configuration for the defibrillation electrodes 42. However, in other examples, the defibrillation electrodes 42 may be coupled to separate conductors within the lead body 13, and therefore may each have a different polarity, so that electrical energy may flow between the defibrillation electrodes 42, or between one of the defibrillation electrodes 42 and one of the pacing / sensing electrodes 44 or the housing electrode, to provide an anti-tachyarrhythmia shock, pacing therapy, and / or to sense cardiac depolarization. In this case, the defibrillation electrodes 42 may still be electrically coupled together, for example, via one or more switches within the ICD 9, to have the same polarity.

[0065] Figure 3 is an example Figure 1 1 is a block diagram of an exemplary configuration of IMD 10. Figure 2 The ICD 9 may have a similar configuration. Figure 3As shown in , IMD 10 includes processing circuitry 50, sensing circuitry 52, communication circuitry 54, memory 56, sensor 58, accelerometer 60, switching circuitry 62, therapy delivery circuitry 64, and electrodes 46A to 46D (hereinafter referred to as "electrodes 46"), one or more of which may be disposed on a housing of IMD 10. In some examples, memory 56 includes computer-readable instructions that, when executed by processing circuitry 50, cause IMD 10 and processing circuitry 50 to perform various functions attributed to IMD 10 and processing circuitry 50 herein. Memory 56 may include any volatile, nonvolatile, magnetic, optical, or electrical medium, such as random access memory (RAM), read-only memory (ROM), nonvolatile RAM (NVRAM), electrically erasable programmable ROM (EEPROM), flash memory, or any other digital medium.

[0066] Processing circuit 50 may include fixed function circuits and / or programmable processing circuits. Processing circuit 50 may include any one or more of a microprocessor, a controller, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field programmable gate array (FPGA), or equivalent discrete or analog logic circuits. In some examples, processing circuit 50 may include multiple components (such as any combination of one or more microprocessors, one or more controllers, one or more DSPs, one or more ASICs, or one or more FPGAs) and other discrete or integrated logic circuits. The functions attributed to processing circuit 50 herein may be embodied in software, firmware, hardware, or any combination thereof.

[0067] The sensing circuit 52 may be selectively coupled to any one or more of the electrodes 46 via the switching circuit 62 controlled by the processing circuit 50. The sensing circuit 52 may monitor the signals from the electrodes 46 to monitor Figure 1 The processing circuit 50 may sense the electrical activity of the heart of patient 4 and generate cardiac EGM data of patient 4. In some examples, the processing circuit 50 may identify features of the sensed cardiac EGM to detect an arrhythmia episode in patient 4. The processing circuit 50 may store the digitized cardiac EGM and features of the EGM used to detect an arrhythmia episode in the memory 56 as episode data of the detected arrhythmia episode. In some examples, the processing circuit 50 stores one or more segments of the cardiac EGM data, features derived from the cardiac EGM data, and other episode data in response to instructions from the external device 12 (for example, when the patient 4 experiences one or more symptoms of an arrhythmia and inputs a command to the external device 12 instructing the IMD 10 to upload data for analysis by a monitoring center or clinician).

[0068] In some examples, the processing circuit 50 transmits the physiological parameter data of the patient 4 and other data (such as seizure data) to an external device such as a Figure 1 For example, the IMD 10 transmits the values ​​of various physiological parameters, digitized cardiac EGM and other episode data to the network 25 for use. Figure 1 The computing system 24 processes the data.

[0069] The sensing circuit 52 and / or the processing circuit 50 can be configured to detect cardiac depolarization (e.g., a P wave for atrial depolarization or an R wave for ventricular depolarization) when the cardiac EGM amplitude exceeds a sensing threshold. In some examples, for cardiac depolarization detection, the sensing circuit 52 may include a rectifier, a filter, an amplifier, a comparator, and / or an analog-to-digital converter. In some examples, the sensing circuit 52 may output an indication to the processing circuit 50 in response to the sensing of cardiac depolarization. In this manner, the processing circuit 50 may receive an indication of detected cardiac depolarization corresponding to the occurrence of detected R waves and P waves in the corresponding chambers of the heart. The processing circuit 50 may use the indications of the detected R waves and P waves to determine characteristics of the cardiac EGM (including depolarization intervals, heart rate) and detect arrhythmias (such as tachyarrhythmias and asystole). The sensing circuit 52 may also provide one or more digitized cardiac EGM signals to the processing circuit 50 for analysis, such as for cardiac rhythm discrimination and / or identifying and characterizing characteristics of the cardiac EGM, such as QRS amplitude and / or width, or other morphological characteristics.

[0070] In some examples, IMD 10 includes one or more sensors 58, such as one or more optical sensors, impedance sensors, microphones, and / or pressure sensors. Sensors 58 may include one or more of additional sensors configured to be controlled based on detected movement, continuously operating sensors, or sensors controlled based on factors other than detected movement.

[0071] In some examples, sensing circuit 52 may include one or more filters and amplifiers for filtering and amplifying signals received from one or more of electrodes 46 and / or other sensors 58. In some examples, sensing circuit 52 and / or processing circuit 50 may include a rectifier, a filter and / or amplifier, a sense amplifier, a comparator, and / or an analog-to-digital converter. Processing circuit 50 may determine a value of a physiological parameter of patient 4 based on the signal from sensor 58, which may be used to identify an arrhythmia episode and stored as episode data in memory 56.

[0072] The communication circuitry 54 may include any suitable hardware, firmware, software, or any combination thereof for securely communicating with another device, such as the external device 12. Under the control of the processing circuitry 50, the communication circuitry 54 may receive downlink telemetry from the external device 12 or another device via an internal antenna or an external antenna (e.g., antenna 26), and transmit uplink telemetry to the external device or another device. In some examples, the processing circuitry 50 may communicate via an external device (e.g., the external device 12) and a Medtronic® communication protocol, such as that developed by Medtronic plc of Dublin, Ireland. A computer network of networks communicates with networked computing devices.

[0073] Therapy delivery circuitry 64 may be selectively coupled to any one or more of electrodes 46 via switching circuitry 62 controlled by processing circuitry 50. Therapy delivery circuitry 64 represents circuitry configured to deliver any of the various therapies described in the present disclosure, including defibrillation therapy and pacing therapy. Therapy delivery circuitry 64 may be configured to deliver defibrillation therapy at various voltage levels in the range of, for example, 500 volts to 800 volts.

[0074] Although described herein in the context of an exemplary IMD 10, the techniques for arrhythmia detection disclosed herein may be used with other types of devices. In some examples, the functionality of the IMD 10 may be implemented by separate sensing devices and therapy delivery devices. The sensing techniques and / or therapy delivery techniques may be used, for example, with an external cardiac defibrillator coupled to electrodes external to the cardiovascular system, a transcatheter pacemaker configured for implantation within the heart (such as the Micra 100 commercially available from Medtronic, Inc. of Dublin, Ireland), or a transcatheter pacemaker configured for implantation within the heart (such as the Micra 100 commercially available from Medtronic, Inc. of Dublin, Ireland). TM transcatheter pacing systems), insertable cardiac monitors (such as the Reveal LINQ TM The invention may be implemented by using an ICM), a neurostimulator, a drug delivery device, a medical device external to the patient 4, a wearable device (such as a wearable cardioverter-defibrillator), a fitness tracker or other wearable device, a mobile device (such as a mobile phone, a "smart" phone, a laptop computer, a tablet computer, a personal digital assistant (PDA)), or "smart" clothing (such as "smart" glasses, a "smart" patch, or a "smart" watch).

[0075] Figure 4A is a block diagram illustrating an exemplary configuration of external device 12. In the illustrated example, external device 12 includes processing circuitry 72 for executing application 94, which may include a heart attack monitoring application or any other application. External device 12 may be any component or system that includes processing circuitry or other suitable computing environment for executing software instructions, and need not include, for example, Figure 4A 74, communication circuitry 76, user interface device 80, or output device 82; and in some examples, components such as storage device 78 may not be in the same location or in the same rack as other components. In some examples, computing system 24 may be a cloud computing system distributed across multiple devices including external device 12.

[0076] exist Figure 4A In some examples, the external device 12 includes a processing circuit 72, one or more input devices 74, a communication circuit 76, one or more storage devices 78, a user interface (UI) device 80, and one or more output devices 82. In some examples, the external device 12 also includes one or more applications 94 and an operating system 86 that can be executed by the external device 12. Each of the components 72, 74, 76, 78, 80, and 82 can be coupled (physically, communicatively, and / or operably) for inter-component communication. In some examples, the communication channel 84 can include a system bus, a network connection, an inter-process communication data structure, or any other method for securely communicating data. For example, the components 72, 74, 76, 78, 80, and 82 can be coupled via one or more communication channels 84.

[0077] In one example, the processing circuit 72 is configured to implement functions and / or process instructions for execution within the external device 12. For example, the processing circuit 72 may be capable of processing instructions stored in the storage device 78. Examples of the processing circuit 72 may include any one or more of the following: a microprocessor, a controller, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field programmable gate array (FPGA), or equivalent discrete or integrated logic circuits.

[0078] One or more storage devices 78 may be configured to store information within the computing device 70 during operation. In some examples, the storage device 78 is described as a computer-readable storage medium. In some examples, the storage device 78 is a temporary memory, which means that the primary purpose of the storage device 78 is not long-term storage. In some examples, the storage device 78 is described as a volatile memory, which means that the storage device 78 does not maintain the stored contents when the computer is turned off. Examples of volatile memory include RAM, dynamic random access memory (DRAM), static random access memory (SRAM), and other forms of volatile memory known in the art. In some examples, the storage device 78 is used to store program instructions executed by the processing circuit 72. In one example, the storage device 78 is used by software or application 94 running on the external device 12 to temporarily store information during program execution.

[0079] In some examples, storage device 78 also includes one or more computer-readable storage media. Storage device 78 may be configured to store a larger amount of information than volatile memory. Storage device 78 may additionally be configured for long-term storage of information. In some examples, storage device 78 includes a non-volatile storage element. Examples of such non-volatile storage elements include a magnetic hard disk, an optical disk, a floppy disk, a flash memory, or various forms of electrically programmable memory (EPROM) or electrically erasable and programmable memory (EEPROM).

[0080] In some examples, the external device 12 also includes communication circuitry 76 to communicate with other devices and systems (such as Figure 1 The IMD 10 and the external device 12 can communicate securely. The communication circuit 76 can include a network interface card, such as an Ethernet card, an optical transceiver, a radio frequency transceiver, or any other type of device that can transmit and receive information. Other examples of such network interfaces can include 3G and Wi-Fi radios.

[0081] In one example, external device 12 also includes one or more user interface devices 80. In some examples, user interface device 80 is configured to receive input from a user through tactile, audio, or video feedback. Examples of user interface device 80 include a presence-sensitive display, a mouse, a keyboard, a voice response system, a camera, a microphone, or any other type of device for detecting commands from a user. In some examples, the presence-sensitive display includes a touch-sensitive screen.

[0082] One or more output devices 82 may also be included in the external device 12. In some examples, the output device 82 is configured to provide output to the user using tactile, audio, or video stimulation. In one example, the output device 82 includes a presence-sensitive display, a sound card, a video graphics adapter card, or any other type of device for converting signals into an appropriate form understandable to humans or machines. Additional examples of output devices 82 include speakers, cathode ray tube (CRT) monitors, liquid crystal displays (LCDs), or any other type of device that can generate understandable output to a user.

[0083] The external device 12 may include an operating system 86. In some examples, the operating system 86 controls the operation of components of the external device 12. For instance, in one example, the operating system 86 facilitates communication of one or more applications 94 with the processing circuitry 72, the communication circuitry 76, the storage device 78, the input device 74, the user interface device 80, and the output device 82.

[0084] The applications 94 may also include program instructions and / or data that are executable by the computing device 70. Exemplary applications 94 that are executable by the computing device 70 may include a cardiac monitoring application or an application for monitoring other conditions of the patient 4. Other additional applications not shown may alternatively or additionally be included to provide other functionality described herein and are not depicted for simplicity.

[0085] According to techniques of this disclosure, external device 12 receives episode data of an episode stored by a medical device, such as IMD 10, via communication circuitry 76. Storage device 78 may store the episode data of the episode in storage device 78. The episode data may have been collected by the medical device in response to the medical device detecting an arrhythmia and / or user input directing storage of the episode data.

[0086] Figure 4B and Figure 4C An example of external device 12 is shown, and more particularly, an example of a display that may be presented to a user of external device 12 in response to IMD 10 detecting an arrhythmia. Figure 4B In the example of , the display device of external device 12 is presenting an alert indicating that IMD 10 has detected a rhythm requiring intervention and is presenting the user with options related to activity level, medication (Rx) use, and recent drug or alcohol use. Figure 4B In the example of , the display of device 12 is also presenting a timer showing that the user has 10 seconds left to make a selection.

[0087] exist Figure 4C In the example of , the display device of external device 12 is presenting an alert indicating that IMD 10 has detected a rhythm requiring intervention and is presenting the user with the option of waiting to see if the problem goes away or the user indicating that they are ready to receive a shock. Figure 4C In the example of , the display of the device 12 is also presenting a timer showing that the user has 10 seconds left to make a selection. As explained above, the external device 12 may be configured to present Figure 4B or Figure 4C The option of only one of Figure 4B The response of the option to conditionally render Figure 4C or vice versa.

[0088] Figure 5 1 shows a flow chart of a process that may be performed by IMD 10 and external device 12. Figure 5In the example of , IMD 10 detects an arrhythmia of patient 4 (102) and determines an initial treatment plan for patient 4. If the arrhythmia requires immediate treatment (104, yes), IMD 10 delivers treatment (106). When the arrhythmia requires immediate treatment, IMD 10 may deliver treatment without giving patient 4 the option to postpone treatment or the option to receive an alternative treatment. If the arrhythmia does not require immediate treatment (104, no), IMD 10 attempts to initiate a communication session with external device 12 (108). In some examples, the attempted communication session is a secure telemetry session. If IMD 10 cannot establish a communication session with external device 12 without timing out (110, yes), IMD 10 does not modify the initial treatment plan (112) and provides applicable treatment to patient 4 (114), which in this scenario will be the initial treatment.

[0089] If the IMD 10 can establish a communication session with the external device 12 without timing out (110, no), the IMD 10 causes the external device 12 to prompt the user for input (116). The prompt and the input may be in various forms and include the above-mentioned information. If the user does not respond within a certain amount of time (e.g., 30 seconds or any other predetermined amount of time) (118, yes), the external device 12 does not cause the IMD to modify the initial treatment plan (112), and the IMD provides the applicable treatment to the patient 4 (114), in which case the applicable treatment will be the initial treatment or the most recently modified treatment plan. If the user responds within a certain amount of time (e.g., 30 seconds or any other predetermined amount of time) (118, no), the external device 12 may cause the IMD 10 to modify the treatment plan based on the input received from the user (120), and the IMD 10 delivers the applicable treatment (114), in which case the applicable treatment may be the treatment plan that has been modified based on the user input. Modification of the treatment plan may include either or both of modifying the treatment plan for the current arrhythmia or modifying the treatment plan for future arrhythmias of the same or similar type. For example, IMD 10 may set the modified treatment plan as the initial treatment plan for future arrhythmias of the same or similar type. In some implementations, IMD 10 or user device 12 may store multiple user inputs or multiple treatment plans resulting from the user inputs, and set the initial treatment plan to the most frequently occurring treatment plan resulting from the user inputs.

[0090] In some examples, IMD 10 may perform one or more of steps 104, 108, 110, 116, 118, and 114 after step 106. That is, IMD 10 may deliver therapy (106), then prompt for user input (116), modify the therapy plan for future arrhythmias (120), and apply the modified therapy plan for future arrhythmias (114).

[0091] Figure 6 1 shows a flow chart of a process that may be performed by IMD 10 without external device 12. Figure 5 In the example of , IMD 10 detects an arrhythmia for patient 4 (132) and determines an initial treatment plan for patient 4. If the arrhythmia requires immediate treatment (134, yes), IMD 10 delivers the treatment (136). When the arrhythmia requires immediate treatment, IMD 10 may deliver the treatment without giving patient 4 the option to postpone the treatment or the option to receive an alternative treatment. If the arrhythmia does not require immediate treatment (134, no), IMD 10 attempts to alert patient 4 that IMD 10 has detected an arrhythmia (138). The alert may be either an audible alert or a tactile alert that may attract the attention of patient 4. If IMD 10 does not receive feedback from patient 4 within a set amount of time (e.g., 30 seconds or any other predetermined amount of time) informing the IMD that an arrhythmia has been detected (140, yes), IMD 10 does not modify the initial treatment plan (142) and provides applicable treatment to patient 4 (144), which in this scenario will be the initial treatment.

[0092] If the IMD 10 receives feedback from the patient 4 before the timeout (e.g., within 30 seconds or any other predetermined amount of time) (140, No), the IMD 10 may determine that the patient 4 wishes to postpone the high voltage therapy (146), and the IMD 10 may modify the therapy plan accordingly (148). The IMD 10 then applies the applicable therapy, which in this case is a modified therapy plan that may delay or postpone the delivery of the high voltage therapy compared to the initial therapy plan. Postponing the high voltage therapy may be applicable to either or both of the therapy plan for the current arrhythmia or the therapy plan for future arrhythmias of the same or similar type. For example, the IMD 10 may set the initial therapy plan for future arrhythmias to also include postponing the high voltage therapy.

[0093] In some examples, IMD 10 may perform one or more of steps 134, 138, 140, 146, 148, and 144 after step 136. That is, IMD 10 may deliver therapy (136), then prompt for user input (146), modify the therapy plan for future arrhythmias (148), and apply the modified therapy plan for future arrhythmias (144).

[0094] In the case where no external computing device like the external device 12 is required Figure 6In the example of FIG. 1 , IMD 10 may be configured to receive feedback or information from patient 4 in any of a variety of ways. In one example, patient 4 may have a simple electronic device in a form similar to a car alarm remote control, such as Figure 7 The device 160 in FIG. 1 includes two buttons, but other implementations may include more or fewer buttons. Figure 7 In the example of FIG. 1 , patient 4 may be able to press first button 162 to confirm the presence of symptoms, which may cause IMD 10 to not postpone delivery of high voltage therapy; or press second button 164 to indicate that the patient wishes to postpone therapy (e.g., for a predetermined amount of time). In other specific implementations, patient 4 may additionally or alternatively be able to postpone therapy by issuing a voice command that can be interpreted by IMD 10, touching a part of their body at a location that can be sensed by IMD 10, making a movement that can be sensed by an accelerometer of IMD 10, or using any other such mechanism.

[0095] In some examples, the technology of the present disclosure includes a system including means for performing any of the methods described herein. In some examples, the technology of the present disclosure includes a computer-readable medium including instructions for causing a processing circuit to perform any of the methods described herein.

[0096] It should be understood that the various aspects disclosed herein may be combined in combinations different from those specifically presented in the specification and drawings. It should also be understood that, depending on the example, certain actions or events of any of the processes or methods described herein may be performed in a different order, may be added, merged, or omitted entirely (e.g., not all described actions or events may be required to perform these techniques). In addition, although certain aspects of the present disclosure are described as being performed by a single module, unit, or circuit for clarity, it should be understood that the techniques of the present disclosure may be performed by a combination of units, modules, or circuits associated with, for example, a medical device.

[0097] In one or more examples, the described techniques can be implemented in hardware, software, firmware, or any combination thereof. If implemented in software, the functions can be stored as one or more instructions or codes on a computer-readable medium and executed by a hardware-based processing unit. The computer-readable medium may include a non-transitory computer-readable medium that corresponds to a tangible medium, such as a data storage medium (e.g., RAM, ROM, EEPROM, flash memory, or any other medium that can be used to store desired program code in the form of instructions or data structures and can be accessed by a computer).

[0098] Instructions may be executed by one or more processors, such as one or more digital signal processors (DSPs), general purpose microprocessors, application specific integrated circuits (ASICs), field programmable logic arrays (FPGAs), or other equivalent integrated or discrete logic circuits. Thus, the terms "processor" or "processing circuitry" as used herein may refer to any of the foregoing structures or any other physical structure suitable for implementing the described techniques. Additionally, these techniques may be fully implemented in one or more circuits or logic elements.

[0099] The following items are illustrative of the techniques and systems described herein.

[0100] Item 1. A method, the method comprising: receiving at an external device an indication from an implantable medical device (IMD) implanted in a patient that the IMD has detected an arrhythmia in the patient; generating, by the external device, an output indicating that the IMD has detected the arrhythmia; receiving at the external device an input from a user of the external device; and in response to the input from the user, sending a command from the external device to the IMD to cause the IMD to modify a treatment plan determined by the IMD.

[0101] Clause 2. The method of Clause 1, wherein the input comprises a request by the user to delay acceptance of defibrillation therapy from the IMD.

[0102] Clause 3. The method of Clause 1, wherein the input comprises a request by the user to expedite receipt of defibrillation therapy from the IMD.

[0103] Clause 4. The method of clause 1, wherein the input comprises an indication of an activity level of the patient.

[0104] Clause 5. The method of clause 1, wherein the input comprises a confirmation from the user that the patient has taken the medication.

[0105] Clause 6. A method according to any one of clauses 1 to 5, wherein the therapy plan includes delivering defibrillation therapy at a first voltage, and the command causes the IMD to modify the therapy plan to include delivering the defibrillation therapy at a second voltage different from the first voltage.

[0106] Clause 7. The method of Clause 6, wherein the command causes the IMD to modify the therapy plan to include delivering the defibrillation therapy at the second voltage that is different from the first voltage in response to the IMD detecting a subsequent arrhythmia of the patient.

[0107] Clause 8. The method of any of Clauses 1 to 5, wherein the therapy plan includes delivering defibrillation therapy, and the command causes the IMD to modify the therapy plan to include pacing therapy instead of the defibrillation therapy.

[0108] Clause 9. The method of clause 8, wherein the command causes the IMD to modify the therapy plan to include delivering the pacing therapy instead of the defibrillation therapy in response to the IMD detecting a subsequent arrhythmia of the patient.

[0109] Clause 10. The method of any one of clauses 1 to 5, wherein the therapy plan includes delivering defibrillation therapy at a first time, and the command causes the IMD to modify the therapy plan to deliver the defibrillation therapy at a second time that is later than the first time.

[0110] Clause 11. The method of clause 10, wherein the therapy plan includes delivering defibrillation therapy at the first time after detecting the arrhythmia, and the command causes the IMD to modify the therapy plan to deliver the defibrillation therapy at the second time after detecting a subsequent arrhythmia.

[0111] Clause 12. A method according to any one of clauses 1 to 11, the method further comprising storing multiple inputs received from the user in response to multiple outputs indicating that the IMD has detected the arrhythmia of the patient, wherein the multiple inputs include the input, and wherein the command causes the IMD to modify the treatment plan based on the multiple inputs.

[0112] Clause 13. The method of Clause 12, wherein the command causes the IMD to modify the treatment plan based on a most frequently occurring input among the plurality of inputs.

[0113] Clause 14. The method according to any one of clauses 1 to 13, further comprising: in response to receiving the indication that the IMD has detected the arrhythmia of the patient, establishing a secure telemetry session between the IMD and the external device to facilitate data transmission between the IMD and the external device.

[0114] Item 15. A device comprising: a memory; and a processing circuit coupled to the memory and configured to: receive an indication from an implantable medical device (IMD) implanted in a patient that the IMD has detected an arrhythmia in the patient; generate an output indicating that the IMD has detected the arrhythmia; receive input from a user of the external device at an external device; and in response to the input from the user, send a command to the IMD to cause the IMD to modify a treatment plan determined by the IMD.

[0115] Clause 16. The apparatus of Clause 15, wherein the input comprises a request by the user to delay acceptance of defibrillation therapy from the IMD.

[0116] Clause 17. The apparatus of Clause 15, wherein the input comprises a request by the user to expedite receipt of defibrillation therapy from the IMD.

[0117] Clause 18. The apparatus of clause 15, wherein the input comprises an indication of an activity level of the patient.

[0118] Clause 19. The apparatus of Clause 15, wherein the input comprises a confirmation from the user that the patient has taken the medication.

[0119] Clause 20. The device of any one of clauses 15 to 19, wherein the therapy plan includes delivering defibrillation therapy at a first voltage, and the command causes the IMD to modify the therapy plan to include delivering the defibrillation therapy at a second voltage different from the first voltage.

[0120] Clause 21. The apparatus of clause 20, wherein the command causes the IMD to modify the therapy plan to include delivering the defibrillation therapy at the second voltage that is different from the first voltage in response to the IMD detecting a subsequent arrhythmia of the patient.

[0121] Clause 22. The device of any of Clauses 15 to 19, wherein the therapy plan includes delivering defibrillation therapy, and the command causes the IMD to modify the therapy plan to include pacing therapy instead of the defibrillation therapy.

[0122] Clause 23. The apparatus of Clause 22, wherein the command causes the IMD to modify the therapy plan to include delivering the pacing therapy instead of the defibrillation therapy in response to the IMD detecting a subsequent arrhythmia of the patient.

[0123] Clause 24. The device of any one of clauses 15 to 19, wherein the therapy plan includes delivering defibrillation therapy at a first time, and the command causes the IMD to modify the therapy plan to deliver the defibrillation therapy at a second time that is later than the first time.

[0124] Clause 25. The device of clause 24, wherein the therapy plan includes delivering defibrillation therapy at the first time after detecting the arrhythmia, and the command causes the IMD to modify the therapy plan to deliver the defibrillation therapy at the second time after detecting a subsequent arrhythmia.

[0125] Clause 26. The apparatus of any of Clauses 15 to 25, wherein the processing circuit is configured to: in response to receiving the indication that the IMD has detected the arrhythmia of the patient, establish a secure telemetry session with the IMD.

[0126] Clause 27. An apparatus as described in any of clauses 15 to 26, wherein the processing circuit is further configured to store multiple inputs received from the user in response to multiple outputs indicating that the IMD has detected the arrhythmia of the patient, wherein the multiple inputs include the input, and wherein the command causes the IMD to modify the treatment plan based on the multiple inputs.

[0127] Clause 28. The apparatus of Clause 27, wherein the command causes the IMD to modify the treatment plan based on a most frequently occurring input of the plurality of inputs.

[0128] Item 29. A system comprising: an implantable medical device (IMD) configured to detect a cardiac arrhythmia in a patient; and an external device comprising a processing circuit and configured to: receive an indication from the IMD that the IMD has detected the cardiac arrhythmia in the patient; generate an output indicating that the IMD has detected the cardiac arrhythmia; receive input from a user; and in response to the input from the user, send a command to the IMD to cause the IMD to modify a treatment plan determined by the IMD.

[0129] Clause 30. The system of Clause 29, wherein the input comprises a request by the user to delay acceptance of defibrillation therapy from the IMD.

[0130] Clause 31. The system of Clause 29, wherein the input comprises a request by the user to expedite receipt of defibrillation therapy from the IMD.

[0131] Clause 32. The system of Clause 29, wherein the input comprises an indication of an activity level of the patient.

[0132] Clause 33. The system of Clause 29, wherein the input comprises a confirmation from the user that the patient has taken the medication.

[0133] Clause 34. A system as described in any of clauses 29 to 34, wherein the therapy plan includes delivering defibrillation therapy at a first voltage, and the command causes the IMD to modify the therapy plan to include delivering the defibrillation therapy at a second voltage different from the first voltage.

[0134] Clause 35. The system of clause 34, wherein the command causes the IMD to modify the therapy plan to include delivering the defibrillation therapy at the second voltage that is different from the first voltage in response to the IMD detecting a subsequent arrhythmia of the patient.

[0135] Clause 36. The system of any of Clauses 29 to 34, wherein the therapy plan includes delivering defibrillation therapy, and the command causes the IMD to modify the therapy plan to include pacing therapy instead of the defibrillation therapy.

[0136] Clause 37. The system of clause 36, wherein the command causes the IMD to modify the therapy plan to include delivering the pacing therapy instead of the defibrillation therapy in response to the IMD detecting a subsequent arrhythmia of the patient.

[0137] Clause 38. The system of any one of clauses 29 to 34, wherein the therapy plan includes delivering defibrillation therapy at a first time, and the command causes the IMD to modify the therapy plan to deliver the defibrillation therapy at a second time that is later than the first time.

[0138] Clause 39. A system as described in clause 38, wherein the treatment plan includes delivering defibrillation therapy at the first time after detecting the arrhythmia, and the command causes the IMD to modify the treatment plan to deliver the defibrillation therapy at the second time after detecting a subsequent arrhythmia.

[0139] Clause 40. A system according to any one of clauses 29 to 39, wherein the processing circuit is further configured to store multiple inputs received from the user in response to multiple outputs indicating that the IMD has detected the arrhythmia of the patient, wherein the multiple inputs include the input, and wherein the command causes the IMD to modify the treatment plan based on the multiple inputs.

[0140] Clause 41. The system of clause 40, wherein the command causes the IMD to modify the treatment plan based on a most frequently occurring input among the plurality of inputs.

[0141] Clause 42. The system of any one of clauses 29 to 41, wherein the IMD is configured to establish a secure telemetry session with the external device to facilitate data transmission between the IMD and the external device in response to the IMD detecting the arrhythmia of the patient.

[0142] Clause 43. The system of any one of clauses 29 to 42, wherein the external device is configured to establish a secure telemetry session with the IMD to facilitate data transmission between the IMD and the external device in response to the IMD detecting the arrhythmia of the patient.

[0143] Clause 44. A computer-readable storage medium storing instructions that, when executed by one or more processors, cause the one or more processors to perform the method of any one of clauses 1 to 14.

[0144] Various embodiments have been described. These and other examples are within the scope of the following claims.

Claims

1. A device, comprising: Memory; and a processing circuit coupled to the memory and configured to: receiving an indication from an implantable medical device (IMD) implanted in a patient that the IMD has detected an arrhythmia in the patient; generating an output indicating that the IMD has detected the arrhythmia; receiving, at an external device, input from a user of the external device; as well as In response to the input from the user, a command is sent to the IMD to cause the IMD to modify a treatment plan determined by the IMD.

2. The apparatus of claim 1, wherein the input comprises a request by the user to delay acceptance of defibrillation therapy from the IMD.

3. The apparatus of claim 1, wherein the input comprises a request by the user to expedite receipt of defibrillation therapy from the IMD.

4. The apparatus of claim 1, wherein the input comprises an indication of an activity level of the patient.

5. The apparatus of claim 1, wherein the input comprises a confirmation from the user that the patient has taken a medication.

6. The apparatus of any one of claims 1 to 5, wherein the therapy plan includes delivering defibrillation therapy at a first voltage, and the command causes the IMD to modify the therapy plan to include delivering the defibrillation therapy at a second voltage different from the first voltage.

7. The apparatus of any one of claims 1 to 5, wherein the therapy plan includes delivering defibrillation therapy, and the command causes the IMD to modify the therapy plan to include pacing therapy instead of the defibrillation therapy.

8. The apparatus of any one of claims 1 to 5, wherein the therapy plan includes delivering defibrillation therapy at a first time, and the command causes the IMD to modify the therapy plan to deliver the defibrillation therapy at a second time that is later than the first time.

9. The apparatus according to any one of claims 1 to 8, wherein the processing circuit is configured to: In response to receiving the indication that the IMD has detected the arrhythmia of the patient, a secure telemetry session with the IMD is established.

10. A system, comprising: an implantable medical device (IMD) configured to detect a cardiac arrhythmia in a patient; and An external device comprising a processing circuit and configured to: receiving from the IMD an indication that the IMD has detected the arrhythmia of the patient; generating an output indicating that the IMD has detected the arrhythmia; receiving input from a user; as well as In response to the input from the user, a command is sent to the IMD to cause the IMD to modify a treatment plan determined by the IMD.

11. The system of claim 10, wherein the input comprises one of a request by the user to delay acceptance of defibrillation therapy from the IMD, a request by the user to expedite acceptance of defibrillation therapy from the IMD, an indication of an activity level of the patient, or a confirmation from the user that the patient has taken medication.

12. The system of claim 10 or 11, wherein the processing circuit is further configured to apply the modified treatment plan to subsequent arrhythmias following the detected arrhythmia.

13. A method comprising: receiving, at an external device, from an implantable medical device (IMD) implanted in a patient, an indication that the IMD has detected an arrhythmia in the patient; generating, by the external device, an output indicating that the IMD has detected the arrhythmia; receiving, at the external device, input from a user of the external device; as well as In response to the input from the user, a command is sent from the external device to the IMD to cause the IMD to modify a treatment plan determined by the IMD.

14. The method of claim 13, wherein the input comprises one of a request by the user to delay acceptance of defibrillation therapy from the IMD, a request by the user to expedite acceptance of defibrillation therapy from the IMD, an indication of the patient's activity level, or a confirmation from the user that the patient has taken medication.

15. The method of claim 13 or 14, wherein the command causes the IMD to apply the modified therapy plan to a subsequent arrhythmia following the detected arrhythmia.